Exciva

Alzinova

This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.

Revivio Therapeutics

This clinical-stage biotechnology company develops small molecule therapeutics for patients with neurodegenerative diseases, including Alzheimer's disease and mild cognitive impairment.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Acumen Pharmaceuticals

This biopharmaceutical company develops novel targeted therapies for patients with Alzheimer's disease by targeting toxic soluble amyloid beta oligomers.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.